{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:57:37Z","timestamp":1794859057314,"version":"4.9.1"},"reference-count":49,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TJAR"],"DOI":"10.4274\/tjar.2026.262459","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:48:27Z","timestamp":1782197307000},"source":"Crossref","is-referenced-by-count":2,"title":["Perioperative Management of Patients using GLP-1 Receptor Agonists Current Evidence, Risks, and Practical Recommendations-A Narrative Review"],"prefix":"10.4274","author":[{"given":"U\u011fur Serkan","family":"\u00c7itilcio\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Kaya","family":"\u00d6zdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"102782","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris","year":"2024","unstructured":"1. Alfaris N, Waldrop S, Johnson V, Boaventura B, Kendrick K, Stanford FC. GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review. EClini-calMedicine. 2024;75:102782.","journal-title":"EClini-calMedicine"},{"issue":"6","key":"ref1","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.amjmed.2025.01.021","article-title":"Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways in appetite and energy regulation","volume":"138","author":"Moiz","year":"2025","unstructured":"2. Moiz A, Filion KB, Tsoukas MA, Yu OH, Peters TM, Eisenberg MJ. Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways in appetite and energy regulation. Am J Med. 2025;138(6):934-940.","journal-title":"Am J Med"},{"issue":"11","key":"ref2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with over-weight or obesity","volume":"384","author":"Wilding","year":"2021","unstructured":"3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with over-weight or obesity. N Engl J Med. 2021;384(11):989-1002.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13741-024-00439-y","article-title":"The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis","volume":"13","author":"do Nascimento","year":"2024","unstructured":"4. do Nascimento TS, Pereira ROL, Maia E, et al. The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis. Perioper Med (Lond). 2024;13(1):78.","journal-title":"Perioper Med (Lond)"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/ACO.0000000000001348","article-title":"Perioperative management of patients on glucagon-like peptide-1 receptor agonists","volume":"37","author":"Mizubuti","year":"2024","unstructured":"5. Mizubuti GB, Ho AM, Silva LMD, Phelan R. Perioperative management of patients on glucagon-like peptide-1 receptor agonists. Curr Opin Anaesthesiol. 2024;37(3):323-333.","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Shankar A, Sharma A, Vinas A, Chilton RJ. GLP-1 receptor agonists and delayed gastric empty-ing: implications for invasive cardiac interventions and surgery. Cardiovasc Endocrinol Metab. 2024;14(1):e00321.","DOI":"10.1097\/XCE.0000000000000321"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26502\/aimr.0189","article-title":"Semaglutide: double-edged sword with risks and benefits","volume":"8","author":"Pillarisetti","year":"2025","unstructured":"7. Pillarisetti L, Agrawal DK. Semaglutide: double-edged sword with risks and benefits. Arch Intern Med Res. 2025;8(1):1-13.","journal-title":"Arch Intern Med Res"},{"issue":"21","key":"ref7","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.3390\/jcm13216336","article-title":"A scoping review of GLP-1 receptor ago-nists: are they associated with increased gastric contents, regurgitation, and aspiration events","volume":"13","author":"Chang","year":"2024","unstructured":"8. Chang MG, Ripoll JG, Lopez E, Krishnan K, Bittner EA. A scoping review of GLP-1 receptor ago-nists: are they associated with increased gastric contents, regurgitation, and aspiration events? J Clin Med. 2024;13(21):6336.","journal-title":"J Clin Med"},{"issue":"2","key":"ref8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bja.2021.04.008","article-title":"Gastric content and perioperative pulmonary aspiration in pa-tients with diabetes mellitus: a scoping review","volume":"127","author":"Xiao","year":"2021","unstructured":"9. Xiao MZ, Englesakis M, Perlas A. Gastric content and perioperative pulmonary aspiration in pa-tients with diabetes mellitus: a scoping review. Br J Anaesth. 2021;127(2):224-235.","journal-title":"Br J Anaesth"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-018-0038-z","article-title":"Gastroparesis","volume":"4","author":"Camilleri","year":"2018","unstructured":"10. Camilleri M, Chedid V, Ford AC, et al. Gastroparesis. Nat Rev Dis Primers. 2018;4(1):41.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"ref10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/sja.sja_351_21","article-title":"Airway management in patients with obesity","volume":"16","author":"Thota","year":"2022","unstructured":"11. Thota B, Jan KM, Oh MW, Moon TS. Airway management in patients with obesity. Saudi J Anaesth. 2022;16(1):76-81.","journal-title":"Saudi J Anaesth"},{"issue":"8","key":"ref11","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/j.1572-0241.2008.01946.x","article-title":"The association between gastroesoph-ageal reflux disease and obesity","volume":"103","author":"Friedenberg","year":"2008","unstructured":"12. Friedenberg FK, Xanthopoulos M, Foster GD, Richter JE. The association between gastroesoph-ageal reflux disease and obesity. Am J Gastroenterol. 2008;103(8):2111-2122.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.25259\/PEAK_19_2024","article-title":"Adoption of GLP-1 receptor agonists in obesity manage-ment and implications for anesthesia and critical care","volume":"1","author":"Browning","year":"2025","unstructured":"13. Browning TE, Coy A, Sehgal V, et al. Adoption of GLP-1 receptor agonists in obesity manage-ment and implications for anesthesia and critical care. Pract Evid Anaesth Knowl. 2025;1(1):9-18.","journal-title":"Pract Evid Anaesth Knowl"},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5114\/ait\/208895","article-title":"A narrative review","volume":"57","author":"Doroba","year":"2025","unstructured":"14. Doroba O, Czupryniak L, Sanfilippo F, Andruszkiewicz P, Zawadka M. New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review. Anaesthesiol Intensive Ther. 2025;57(1):231-238.","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s44158-025-00237-y","article-title":"A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia","volume":"5","author":"Vetrugno","year":"2025","unstructured":"15. Vetrugno L, Deana C, Da Porto A, et al. A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia. J Anesth Analg Crit Care. 2025;5(1):16.","journal-title":"J Anesth Analg Crit Care"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Jones PM, Hobai IA, Murphy PM. Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution! Can J Anaesth. 2023;70(8):1281-1286.","DOI":"10.1007\/s12630-023-02550-y"},{"key":"ref16","unstructured":"17. Joshi GP, Abdelmalak BB, Weigel WA, et al. ASA consensus-based guidance on preoperative management of patients on GLP-1 receptor agonists. October, 2024. Accessed February 4, 2026."},{"issue":"1","key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/EJA.0000000000002069","article-title":"Preoperative assessment of adults undergoing elective noncardiac surgery: updated guidelines from the European Society of Anaesthesiology and Intensive Care","volume":"42","author":"Lamperti","year":"2025","unstructured":"18. Lamperti M, Romero CS, Guarracino F, et al. Preoperative assessment of adults undergoing elective noncardiac surgery: updated guidelines from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol. 2025;42(1):1-35.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bja.2025.04.001","article-title":"Perioperative management of patients taking gluca-gon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Im-provement (SPAQI) multidisciplinary consensus statement","volume":"135","author":"Oprea","year":"2025","unstructured":"19. Oprea AD, Ostapenko LJ, Sweitzer B, et al. Perioperative management of patients taking gluca-gon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Im-provement (SPAQI) multidisciplinary consensus statement. Br J Anaesth. 2025;135(1):48-78.","journal-title":"Br J Anaesth"},{"issue":"5","key":"ref19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/0310057X251355288","article-title":"2025 ADS\/ANZCA\/GESA\/NACOS clinical practice recommendations on the peri-procedural use of GLP-1\/GIP receptor agonists","volume":"53","author":"Hocking","year":"2025","unstructured":"20. Hocking SL, Scott DA, Remedios ML, et al. 2025 ADS\/ANZCA\/GESA\/NACOS clinical practice recommendations on the peri-procedural use of GLP-1\/GIP receptor agonists. Anaesth Inten-sive Care. 2025;53(5):300-306.","journal-title":"Anaesth Inten-sive Care"},{"issue":"4","key":"ref20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/anae.16541","article-title":"Elective peri-operative management of adults taking glu-cagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: a consensus statement from the Association of Anaesthetists, Association of British Clinical Di-abetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesi-ty and Bariatric Anaesthesia and UK Clinical Pharmacy Association","volume":"80","author":"El-Boghdadly","year":"2025","unstructured":"21. El-Boghdadly K, Dhesi J, Fabb P, et al. Elective peri-operative management of adults taking glu-cagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: a consensus statement from the Association of Anaesthetists, Association of British Clinical Di-abetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesi-ty and Bariatric Anaesthesia and UK Clinical Pharmacy Association. Anaesthesia. 2025;80(4):412-424.","journal-title":"Anaesthesia"},{"issue":"8","key":"ref21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/dom.12251","article-title":"The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems","volume":"16","author":"Seufert","year":"2014","unstructured":"22. Seufert J, Gallwitz B. The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems. Diabetes Obes Metab. 2014;16(8):673-688.","journal-title":"Diabetes Obes Metab"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"112722","DOI":"10.1016\/j.biopha.2022.112722","article-title":"Small-molecule albumin ligand modification to enhance the anti-diabetic ability of GLP-1 derivatives","volume":"148","author":"Sun","year":"2022","unstructured":"23. Sun X, Zhang Z, Liu M, et al. Small-molecule albumin ligand modification to enhance the anti-diabetic ability of GLP-1 derivatives. Biomed Pharmacother. 2022;148:112722.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"ref23","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bja.2024.01.001","article-title":"Perioperative management of long-acting GLP-1 receptor agonists","volume":"132","author":"van Zuylen","year":"2024","unstructured":"24. van Zuylen ML, Siegelaar SE, Plummer MP, et al. Perioperative management of long-acting GLP-1 receptor agonists. Br J Anaesth. 2024;132(4):644-648.","journal-title":"Br J Anaesth"},{"issue":"4","key":"ref24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","unstructured":"25. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740-756.","journal-title":"Cell Metab"},{"issue":"8","key":"ref25","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1007\/s12630-023-02549-5","article-title":"Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide","volume":"70","author":"Sherwin","year":"2023","unstructured":"26. Sherwin M, Hamburger J, Katz D, DeMaria S Jr. Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide. Can J Anaesth. 2023;70(8):1300-1306.","journal-title":"Can J Anaesth"},{"issue":"12","key":"ref26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/anae.16454","article-title":"Relationship between residual gastric con-tent and peri-operative semaglutide use assessed by gastric ultrasound: a prospective obser-vational study","volume":"79","author":"Nersessian","year":"2024","unstructured":"27. Nersessian RSF, da Silva LM, Carvalho MAS, et al. Relationship between residual gastric con-tent and peri-operative semaglutide use assessed by gastric ultrasound: a prospective obser-vational study. Anaesthesia. 2024;79(12):1317-1324.","journal-title":"Anaesthesia"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"111668","DOI":"10.1016\/j.jclinane.2024.111668","article-title":"Effect of various perioperative semaglutide interrup-tion intervals on residual gastric content assessed by esophagogastroduodenoscopy: a retro-spective single center observational study","volume":"99","author":"Santos","year":"2024","unstructured":"28. Santos LB, Mizubuti GB, da Silva LM, et al. Effect of various perioperative semaglutide interrup-tion intervals on residual gastric content assessed by esophagogastroduodenoscopy: a retro-spective single center observational study. J Clin Anesth. 2024;99:111668.","journal-title":"J Clin Anesth"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Cymbal M, Naseem Z, Hoxha D, Garg S. Impact of GLP-1 receptor agonists on whole-gut gas-trointestinal motility using wireless motility capsule: a descriptive single-center case series. ACG Case Rep J. 2025;12(8):e01789.","DOI":"10.14309\/crj.0000000000001789"},{"issue":"8","key":"ref29","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s12630-023-02521-3","article-title":"Regurgitation under anesthesia in a fasted patient prescribed semag-lutide for weight loss: a case report","volume":"70","author":"MA","year":"2023","unstructured":"30. Gulak MA, Murphy P. Regurgitation under anesthesia in a fasted patient prescribed semag-lutide for weight loss: a case report. Can J Anaesth. 2023;70(8):1397-1400.","journal-title":"Can J Anaesth"},{"issue":"8","key":"ref30","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s12630-023-02440-3","article-title":"Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspi-ration: a case report","volume":"70","author":"SR","year":"2023","unstructured":"31. Klein SR, Hobai IA. Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspi-ration: a case report. Can J Anaesth. 2023;70(8):1394-1396.","journal-title":"Can J Anaesth"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Nauck MA, Meier JJ. Incretin hormones: their role in health and disease. Diabetes Obes Metab. 2018;20(Suppl 1):5-21.","DOI":"10.1111\/dom.13129"},{"issue":"19","key":"ref32","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","unstructured":"33. Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834-1844.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1038\/s41598-024-55724-z","article-title":"The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function","volume":"14","author":"Wajdlich","year":"2024","unstructured":"34. Wajdlich M, Nowicki M. The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function. Sci Rep. 2024;14(1):5002.","journal-title":"Sci Rep"},{"issue":"4","key":"ref34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/dom.14944","article-title":"Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity","volume":"25","author":"Jensterle","year":"2023","unstructured":"35. Jensterle M, Ferjan S, Le\u017eai\u010d L, et al. Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity. Diabetes Obes Metab. 2023;25(4):975-984.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"ref35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/anae.70129","article-title":"Gastric ultrasound in patients receiving semag-lutide: a prospective, multicentre, matched control study","volume":"81","author":"Vlaeminck","year":"2026","unstructured":"36. Vlaeminck N, Van de Putte P, Dekeyser M, et al. Gastric ultrasound in patients receiving semag-lutide: a prospective, multicentre, matched control study. Anaesthesia. 2026;81(6):801-809.","journal-title":"Anaesthesia"},{"issue":"10","key":"ref36","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1111\/dom.15802","article-title":"Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: a randomized controlled tri-al","volume":"26","author":"Gabe","year":"2024","unstructured":"37. Gabe MBN, Breitschaft A, Knop FK, et al. Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: a randomized controlled tri-al. Diabetes Obes Metab. 2024;26(10):4480-4489.","journal-title":"Diabetes Obes Metab"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"111091","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","unstructured":"38. Silveira SQ, da Silva LM, de Campos Vieira Abib A, et al. Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth. 2023;87:111091.","journal-title":"J Clin Anesth"},{"issue":"18","key":"ref38","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.3390\/jcm13185403","article-title":"Real-world impact of GLP-1 receptor ago-nists on endoscopic patient outcomes in an ambulatory setting: a retrospective study at a large tertiary center","volume":"13","author":"Robalino Gonzaga","year":"2024","unstructured":"39. Robalino Gonzaga E, Farooq A, Mohammed A, et al. Real-world impact of GLP-1 receptor ago-nists on endoscopic patient outcomes in an ambulatory setting: a retrospective study at a large tertiary center. J Clin Med. 2024;13(18):5403.","journal-title":"J Clin Med"},{"issue":"7","key":"ref39","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/dom.14373","article-title":"Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes","volume":"23","author":"Dahl","year":"2021","unstructured":"40. Dahl K, Brooks A, Almazedi F, Hoff ST, Boschini C, Baekdal TA. Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Diabetes Obes Metab. 2021;23(7):1594-1603.","journal-title":"Diabetes Obes Metab"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Muranaka MO, Nguyen TH, Wang AT, et al. Role of gastric point-of-care ultrasound in periopera-tive management of semaglutide. Cureus. 2025;17(6):e85791.","DOI":"10.7759\/cureus.85791"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. Skidmore KL, Le H, Segredo V, et al. Pulse oximetry desaturation in the postoperative recovery room in patients with obesity and diabetes using GLP-1 agonists: a retrospective observational study. Cureus. 2025;17(7):e87774.","DOI":"10.7759\/cureus.87774"},{"issue":"6","key":"ref42","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and resid-ual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","unstructured":"43. Sen S, Potnuru PP, Hernandez N, et al. Glucagon-like peptide-1 receptor agonist use and resid-ual gastric content before anesthesia. JAMA Surg. 2024;159(6):660-667.","journal-title":"JAMA Surg"},{"issue":"1","key":"ref43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13741-025-00603-y","article-title":"Perioperative bronchoaspiration in a semaglutide user on a residue-free diet: a case report and insights from a complication","volume":"14","author":"Barbosa Santos","year":"2025","unstructured":"44. Barbosa Santos L, Muniz da Silva L, Silveira SQ, et al. Perioperative bronchoaspiration in a semaglutide user on a residue-free diet: a case report and insights from a complication. Peri-oper Med (Lond). 2025;14(1):115.","journal-title":"Peri-oper Med (Lond)"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45. Queiroz VNF, Falsarella PM, Chaves RCF, Takaoka F, Socolowski LR, Garcia RG. Risk of pulmo-nary aspiration during semaglutide use and anesthesia in a fasting patient: a case report with tomographic evidence. Einstein (Sao Paulo). 2023;21:eRC0628.","DOI":"10.31744\/einstein_journal\/2023RC0628"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46. Jones M, Cappola JJ. GLP-1 receptor agonists in diabetes and obesity: a case report and review of bowel obstruction risks and management. Cureus. 2025;17(4):e81891.","DOI":"10.7759\/cureus.81891"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47. Singhal R, Sachdeva D, Wortman Ii K, Lall R. Unmasking semaglutide-induced gastroparesis: the dangers of rapid dose escalation in a diabetic patient. Cureus. 2025;17(9):e91679.","DOI":"10.7759\/cureus.91679"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48. Chaudhry A, Gabriel B, Noor J, Jawad S, Challa SR. Tendency of semaglutide to induce gastro-paresis: a case report. Cureus. 2024;16(1):e52564.","DOI":"10.7759\/cureus.52564"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49. Essilfie-Quaye K, Maule G, Hashim H, Khraisat M, Okonoboh P, Jantz M. Semaglutide-induced silent aspiration: an unrecognised cause of organising pneumonia. Respirol Case Rep. 2025;13(7):e70249.","DOI":"10.1002\/rcr2.70249"}],"container-title":["Turkish Journal of Anaesthesiology and Reanimation"],"original-title":[],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:57:37Z","timestamp":1782719857000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjanaesthesiolreanim.org\/articles\/perioperative-management-of-patients-using-glp-1-receptor-agonists-current-evidence-risks-and-practical-recommendations-a-narrative-review\/doi\/TJAR.2026.262459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":49,"URL":"https:\/\/doi.org\/10.4274\/tjar.2026.262459","relation":{},"ISSN":["1304-0871","1305-614X"],"issn-type":[{"value":"1304-0871","type":"print"},{"value":"1305-614X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}